Balance Sheet Data

Horizon Therapeutics Public Limited... (HZNP)

$116.3

+0.05 (+0.04%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 958.711,076.292,079.911,580.322,352.833,603.754,829.236,471.438,672.0811,621.07
Total Cash (%)
Account Receivables 464.73408.68659.70632.78676.351,343.691,800.622,412.943,233.474,333.03
Account Receivables (%)
Inventories 50.7553.8075.28225.73169.56227.90305.39409.25548.41734.90
Inventories (%)
Accounts Payable 30.2821.5137.7130.12155.80107.99144.72193.93259.88348.25
Accounts Payable (%)
Capital Expenditure -16.77-17.86-199.85-126.17-126.28-187.08-250.70-335.95-450.20-603.29
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.